Parks Associates: 46% of U.S. Broadband Households Own a Connected Health Device

DALLAS, July 30, 2018 /PRNewswire/ -- Parks Associates research finds 46% of U.S. broadband households now own a connected health device, such as a digital pedometer, smart watch, or a digital weight scale. The research firm will host its fifth-annual Connected Health Summit: Engaging Consumers, August 28-30 at the Manchester Grand Hyatt in San Diego.

"Eighty percent of U.S. broadband households report at least one health management challenge with which they would like help. In many cases, connected technologies can be part of the solution," said Jennifer Kent, Director, Research Quality & Product Development, Parks Associates. "Connected Health Summit's unmatched list of speakers will offer key insights on strategies to increase consumer adoption and improve usage of connected health solutions to achieve better outcomes."

The conference features keynotes from:

Speakers:

  • Bryan Adams, CCO, GreatCall
  • Martin Adler, Chief Strategy Officer, Reflexion Health
  • Sam Ahn, Senior Manager, Healthcare, Samsung Electronics America
  • Timo Aittokoski, Chief Scientist, Emfit
  • Andrew Altorfer, Co-Founder and CEO, CirrusMD
  • Peter Antall, CMO, American Well
  • David Bardan, VP, Provider Solutions, Tyto Care
  • Christopher Baskin, CEO, American Two-Way
  • Daniel Behrendt, Director, Honeywell Life Care Solutions
  • Christopher Bui, Executive Medical Director, Humana
  • John Carpenter, VP, Channel Engagement, Nortek Security and Control
  • Alistair Chatwin, VP & GM, DISH Business
  • Amy Cook, Director, Product Marketing, Connected Devices, ResMed
  • Kent E. Dicks, CEO and Founder, Life365
  • Terry Duesterhoeft, President & CEO, A&D Company -- Americas
  • Angie Kalousek Ebrahimi, Director, Markets, Lifestyle Medicine, Blue Shield of California
  • Rob Flippo, CEO, MobileHelp
  • Jennifer Fraser, Director, User Experience, Macadamian
  • John Gardner, Partner, NGP Capital
  • Paul Geevarghese, VP, Market Access North America, mySugr
  • Mark Goettling, CEO, BodiMetrics
  • Nancy Green, Global Practice Lead - Healthcare, Verizon
  • Geoff Gross, Founder & CEO, Medical Guardian
  • Robert Havasy, Director, Health Information Systems, Personal Connected Health Alliance
  • Chuck Hector, Chief Sales Officer, MDLIVE
  • Jody Holtzman, Senior Managing Partner, Longevity Venture Advisors
  • Dave Johnson, Director, Residential Home Health, ADT
  • Matt Jones, Senior Product Manager, Data Science, Validic
  • Harish Kilaru, Director, Business Development, Cardiogram
  • Joe Liu, CEO, Mivatek Smart Connect
  • Andy Maloy, VP, Connected Health and Business Development, Integron
  • Phil Marshall, Co-founder & Chief Product Officer, Conversa Health
  • Robert Mittendorff, Partner, Norwest Venture Partners
  • Spencer Moore, VP, Sales & Marketing, Rapid Response Monitoring Services
  • Lainie Muller, Director, Wellness, Alarm.com
  • Daniel Nathrath, Founder & CEO, Ada Health
  • Chris Nicholson, Co-founder & CEO, mPulse Mobile
  • Michael Nova, CIO and Founder, Pathway OME
  • Stuart Patterson, CEO, LifePod
  • Jeff Patton, GM Connected Home Products, GE Lighting
  • Karissa Price, COO, EarlySense
  • Jim Pursley, Chief Commercial Officer, Livongo
  • Shanthi Ramakrishnan, CEO, eDevice
  • Roy Raymann, VP, Sleep Science & Scientific Affairs, SleepScore Labs
  • Tad Reynes, Regional VP - Healthcare Solutions, AT&T
  • Kian Saneii, Founder & CEO, Independa
  • Jim Seles, Director, Data and Digital Innovations, Medtronic Diabetes
  • J. Corey Schmid, General Partner, Seven Peaks Ventures
  • Rob Schneider, VP, Sales and Marketing, Omron Healthcare
  • Himanshu Shah, CIO, Care Innovations, an Intel company
  • Prentiss Taylor, VP, Medical Affairs, Doctor On Demand
  • Nathan Treloar, President & COO, Orbita
  • John Valiton, CEO, Reemo Health
  • Doug Wolfgram, CTO, CareSpan International
  • Michael Wu, VP, GM, SleepIQ LABS, SleepNumber

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.